In model 1, after adjusted for age, gender and BMI, only ApoA1 level in male NAFLD patients was significantly associated with baPWV (OR, 1.93; 95% CI [1.22–3.05], P < 0.001). Here, APOA1 is linked to metabolic dysfunction-associated steatotic liver disease.